There we go. Nice big healthy buy to kick things off. And why wouldn't you at these levels. Any positive outcome from the arbitration with a payout exceeding current annual expenditure ($8mil) plus the daptomycin license back in our hands will see at least a 100% increase in share price (or it should) IMO. I think investors at this level will be ecstatic if that payout is multiples of annual expenditure.
Mylan arbitration
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(20.0%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $408 | 154.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 61 | 90794613 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 54998583 | 13 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |